CASEY CROES: Open Payments
NPI 1427240100 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,478 in 161 payments from 22 companies in 2025. Trend: 2023 $1,187 · 2024 $2,647 · 2025 $3,478
Food & beverage: $3,379Education: $99
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 36 | $653 |
| UCB, Inc. | 17 | $374 |
| Janssen Biotech, Inc. | 11 | $352 |
| Novartis Pharmaceuticals Corporation | 14 | $316 |
| GENZYME CORPORATION | 9 | $298 |
| PFIZER INC. | 16 | $293 |
| LEO Pharma Inc. | 9 | $200 |
| MAYNE PHARMA COMMERCIAL LLC | 12 | $175 |
| Regeneron Healthcare Solutions, Inc. | 7 | $162 |
| Amgen Inc. | 7 | $141 |
Products named: DUPIXENT, SKYRIZI, Bimzelx, TREMFYA, RINVOQ, CIBINQO, ADBRY, OTEZLA.
Industry payments across FL — which companies pay providers there.
